Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Asymptomatic Multiple Myeloma - Background of Progression, Evolution, and Prognosis

Blood (2016) 128 (22): 235.

https://doi.org/10.1182/blood.V128.22.235.235

Published: 2016

Journal Articles

Tumor cells in multiple myeloma patients inhibit myeloma-reactive T cells through carcinoembryonic antigen-related cell adhesion molecule-6

Blood (2013) 121 (22): 4493–4503.

https://doi.org/10.1182/blood-2012-05-429415

Published: 2013

Includes: Supplemental data

Journal Articles

Human Multiple Myeloma and Breast Cancer Cells Evade Immune Rejection Through Expression of Carcinoembryonic Antigen-Related Cell Adhesion Molecule 6.

Mathias Witzens-Harig, MD, Dirk Hose, MD, PhD, Simone Jünger, Christina Pfirschke, Nisit Khandelwal, Anja Seckinger, MD, Heinke Conrad, Bettina Brackertz, Thierry Reme, Brigittte Gückel, Tobias Meissner, Michael Hundemer, Anthony D Ho, MD, Jean-Francois Rossi, MD, PhD, Kai Neben, MD, Helga Bernhard, MD, Hartmut Goldschmidt, MD, Bernard Klein, Philipp Beckhove

Blood (2012) 120 (21): 2942.

https://doi.org/10.1182/blood.V120.21.2942.2942

Published: 2012

Journal Articles

Clinical and prognostic role of annexin A2 in multiple myeloma

Anja Seckinger, Tobias Meiβner, Jérôme Moreaux, Daniela Depeweg, Jens Hillengass, Katja Hose, Thierry Rème, Angela Rösen-Wolff, Anna Jauch, Reinhard Schnettler, Volker Ewerbeck, Hartmut Goldschmidt, Bernard Klein, Dirk Hose

Blood (2012) 120 (5): 1087–1094.

https://doi.org/10.1182/blood-2012-03-415588

Published: 2012

Includes: Supplemental data

Journal Articles

Survivin in Multiple Myeloma: Prognostic and Therapeutic Implications

Verena Wagner, Dirk Hose, MD, Anja Seckinger, Ludmila Weitz, MSc, Tobias Meißner, Thierry Reme, Jean-Francois Rossi, MD, PhD, Hartmut Goldschmidt, MD, Alwin Krämer, MD, Bernard Klein, Marc S Raab, MD

Blood (2011) 118 (21): 137.

https://doi.org/10.1182/blood.V118.21.137.137

Published: 2011

Journal Articles

Osteoclast-gene expression profiling reveals osteoclast-derived CCR2 chemokines promoting myeloma cell migration

Jerome Moreaux, Dirk Hose, Alboukadel Kassambara, Thierry Reme, Philippe Moine, Guilhem Requirand, Hartmut Goldschmidt, Bernard Klein

Blood (2011) 117 (4): 1280–1290.

https://doi.org/10.1182/blood-2010-04-279760

Published: 2011

Includes: Supplemental data

Journal Articles

Induction of angiogenesis by normal and malignant plasma cells

Dirk Hose, Jérôme Moreaux, Tobias Meissner, Anja Seckinger, Hartmut Goldschmidt, Axel Benner, Karène Mahtouk, Jens Hillengass, Thierry Rème, John De Vos, Michael Hundemer, Maud Condomines, Uta Bertsch, Jean-François Rossi, Anna Jauch, Bernard Klein, Thomas Möhler

Blood (2009) 114 (1): 128–143.

https://doi.org/10.1182/blood-2008-10-184226

Published: 2009

Includes: Supplemental data

Journal Articles

The role of IGF-1 as a major growth factor for myeloma cell lines and the prognostic relevance of the expression of its receptor

Anne Catherine Sprynski, Dirk Hose, Laurent Caillot, Thierry Réme, John D. Shaughnessy, Jr, Bart Barlogie, Anja Seckinger, Jérôme Moreaux, Michael Hundemer, Michel Jourdan, Tobias Meißner, Anna Jauch, Karène Mahtouk, Alboukadel Kassambara, Uta Bertsch, Jean François Rossi, Hartmut Goldschmidt, Bernard Klein

Blood (2009) 113 (19): 4614–4626.

https://doi.org/10.1182/blood-2008-07-170464

Published: 2009

Journal Articles

Inhibition of aurora kinases for tailored risk-adapted treatment of multiple myeloma

Blood (2009) 113 (18): 4331–4340.

https://doi.org/10.1182/blood-2008-09-178350

Published: 2009

Includes: Supplemental data

Journal Articles

Unsupervised Analysis of Gene Expression Profile of 37 Human Myeloma Cell Lines Identifies 5 Classes of HMCL Characterized by a Set of 213 Genes Related to Molecular Classification of Patients with Multiple Myeloma

Jerome Moreaux, Bernard Klein, Thierry Reme, Michel Jourdan, Sophie Maiga, Régis Bataille, Martine Amiot, Catherine Pellat-Deceunynck

Blood (2008) 112 (11): 2702.

https://doi.org/10.1182/blood.V112.11.2702.2702

Published: 2008

Journal Articles

Angiogenic Signature of Multiple Myeloma Determined by Gene Expression Profiling.

Blood (2007) 110 (11): 2484.

https://doi.org/10.1182/blood.V110.11.2484.2484

Published: 2007

Journal Articles

Gene Expression Profiling and Real-Time PCR Analyses Make It Possible To Identify Novel Potential Cancer-Testis Antigens in Multiple Myeloma.

Maud Condomines, PhD, Dirk Hose, PhD, MD, Thierry Reme, PhD, John de Vos, PhD, MD, Guilhem Requirand, Jean-Francois Rossi, PhD, MD, Hartmunt Goldschmidt, PhD, MD, Bernard Klein

Blood (2007) 110 (11): 1793.

https://doi.org/10.1182/blood.V110.11.1793.1793

Published: 2007

Journal Articles

Heparanase influences expression and shedding of syndecan-1, and its expression by the bone marrow environment is a bad prognostic factor in multiple myeloma

Karène Mahtouk, Dirk Hose, Pierre Raynaud, Michael Hundemer, Michel Jourdan, Eric Jourdan, Veronique Pantesco, Marion Baudard, John De Vos, Marion Larroque, Thomas Moehler, Jean-Francois Rossi, Thierry Rème, Hartmut Goldschmidt, Bernard Klein

Blood (2007) 109 (11): 4914–4923.

https://doi.org/10.1182/blood-2006-08-043232

Published: 2007

Journal Articles

CD200 is a new prognostic factor in multiple myeloma

Jerome Moreaux, Dirk Hose, Thierry Reme, Eric Jourdan, Michael Hundemer, Eric Legouffe, Philippe Moine, Philippe Bourin, Marion Moos, Jill Corre, Thomas Möhler, John De Vos, Jean Francois Rossi, Hartmut Goldschmidt, Bernard Klein

Blood (2006) 108 (13): 4194–4197.

https://doi.org/10.1182/blood-2006-06-029355

Published: 2006

Includes: Supplemental data

Journal Articles

Cancer/Testis Genes in Multiple Myeloma: Expression Patterns and Vaccination Strategies Determined by Microarray Analysis.

Maud Condomines, PharmD, Dirk Hose, MD, PhD, Thierry Reme, PhD, Michael Hundemer, John De Vos, MD, PhD, Marion Baudard, MD, PhD, Thomas Moehler, Veronique Pantesco, Jean-Francois Schved, MD, PhD, Jean-Francois Rossi, MD, PhD, Hartmut Goldschmidt, MD, PhD, Bernard Klein, PhD

Blood (2006) 108 (11): 3401.

https://doi.org/10.1182/blood.V108.11.3401.3401

Published: 2006

Journal Articles

Inhibition of Multiple Myeloma Cells Growth by AS602868, a Pharmacological Inhibitor of IKK2.

Michel Jourdan, PhD, Jerome Moreaux, PhD, Dirk Hose, MD, Jean-Francois Rossi, MD, PhD, Karène Mahtouk, PhD, Mathieu Aboulaze, Nicolas Robert, Marion Baudard, MD, PhD, Thierry Reme, MD, PhD, Angela Romanelli, Hartmut Goldschmidt, MD, Michel Dreano, PhD, Bernard Klein, MD, PhD

Blood (2006) 108 (11): 3472.

https://doi.org/10.1182/blood.V108.11.3472.3472

Published: 2006

Journal Articles

Heparanase Influences Expression and Shedding of Syndecan-1, and Its Expression by the Bone Marrow Environment Is a Bad Prognostic Factor in Multiple Myeloma.

Karene Mahtouk, Dirk Hose, Thierry Reme, Michael Hundemer, Michel Jourdan, Eric Jourdan, Veronique Pantesco, Marion Baudard, John De Vos, Marion Larroque, Thomas Moehler, Jean-Francois Rossi, Hartmut Goldschmidt, Bernard Klein

Blood (2006) 108 (11): 3502.

https://doi.org/10.1182/blood.V108.11.3502.3502

Published: 2006

Journal Articles

TACI and BCMA, Unlike BAFF-R, Are Expressed by Human Myeloma Cell Lines and TACI + Cell Lines Have a Gene Signature Indicative of Mature Bone Marrow Plasma Cells and Bone Marrow Environment Dependence.

Jerome Moreaux, Friedrich W. Cremer, Thierry Reme, Karene Mahtouk, Veronique Pantesco, John de Vos, Marion Moos, Nicolas Robert, Hartmut Goldschmidt, Jean-François Rossi, Dirk Hose, Bernard Klein

Blood (2005) 106 (11): 3400.

https://doi.org/10.1182/blood.V106.11.3400.3400

Published: 2005

Journal Articles

The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signature

Jérôme Moreaux, Friedrich W. Cremer, Thierry Reme, Marc Raab, Karene Mahtouk, Philine Kaukel, Veronique Pantesco, John De Vos, Eric Jourdan, Anna Jauch, Eric Legouffe, Marion Moos, Genevieve Fiol, Hartmut Goldschmidt, Jean François Rossi, Dirk Hose, Bernard Klein

Blood (2005) 106 (3): 1021–1030.

https://doi.org/10.1182/blood-2004-11-4512

Published: 2005

Includes: Supplemental data

Journal Articles

A New Molecular Classification of Multiple Myeloma Using Gene Expression Profiling and Fluorescence In Situ Hybridisation as Predictor for Event Free Survival.

Dirk Hose, Jean-Francois Rossi, Carina Ittrich, John deVos, Axel Benner, Thierry Reme, Jelena Bila, Veronique Grau, Marc Raab, Philine Kaukel, Eric Jourdan, Marion Moos, Ann-Cathrin Theil, Anna Jauch, Hartmut Goldschmidt, Bernard Klein, Friedrich W. Cremer

Blood (2004) 104 (11): 73.

https://doi.org/10.1182/blood.V104.11.73.73

Published: 2004

NARROW

Asymptomatic Multiple Myeloma - Background of Progression, Evolution, and Prognosis

Tumor cells in multiple myeloma patients inhibit myeloma-reactive T cells through carcinoembryonic antigen-related cell adhesion molecule-6

Human Multiple Myeloma and Breast Cancer Cells Evade Immune Rejection Through Expression of Carcinoembryonic Antigen-Related Cell Adhesion Molecule 6.

Clinical and prognostic role of annexin A2 in multiple myeloma

Survivin in Multiple Myeloma: Prognostic and Therapeutic Implications

Osteoclast-gene expression profiling reveals osteoclast-derived CCR2 chemokines promoting myeloma cell migration

Induction of angiogenesis by normal and malignant plasma cells

The role of IGF-1 as a major growth factor for myeloma cell lines and the prognostic relevance of the expression of its receptor

Inhibition of aurora kinases for tailored risk-adapted treatment of multiple myeloma

Unsupervised Analysis of Gene Expression Profile of 37 Human Myeloma Cell Lines Identifies 5 Classes of HMCL Characterized by a Set of 213 Genes Related to Molecular Classification of Patients with Multiple Myeloma

Angiogenic Signature of Multiple Myeloma Determined by Gene Expression Profiling.

Gene Expression Profiling and Real-Time PCR Analyses Make It Possible To Identify Novel Potential Cancer-Testis Antigens in Multiple Myeloma.

Heparanase influences expression and shedding of syndecan-1, and its expression by the bone marrow environment is a bad prognostic factor in multiple myeloma

CD200 is a new prognostic factor in multiple myeloma

Cancer/Testis Genes in Multiple Myeloma: Expression Patterns and Vaccination Strategies Determined by Microarray Analysis.

Inhibition of Multiple Myeloma Cells Growth by AS602868, a Pharmacological Inhibitor of IKK2.

Heparanase Influences Expression and Shedding of Syndecan-1, and Its Expression by the Bone Marrow Environment Is a Bad Prognostic Factor in Multiple Myeloma.

TACI and BCMA, Unlike BAFF-R, Are Expressed by Human Myeloma Cell Lines and TACI + Cell Lines Have a Gene Signature Indicative of Mature Bone Marrow Plasma Cells and Bone Marrow Environment Dependence.

The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signature

A New Molecular Classification of Multiple Myeloma Using Gene Expression Profiling and Fluorescence In Situ Hybridisation as Predictor for Event Free Survival.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only